Latka logo
Curi Bio logo

Curi Biorevenue & acquisition

Drug Discovery SoftwareSeattle, WashingtonFounded 2015

Curi Bio was acquired.

Curi Bio is a pioneering company at the forefront of medical innovation, dedicated to accelerating the discovery of the next generation of medicines. It achieves this through an integrated approach that combines human cells, systems, and data.

curibio.comLinkedInUpdated Oct 5, 2026
Annual revenue
$3.8M
Dec 2023EST
Owner
Undisclosed
Date not on record
Employees
52
Dec 2023EST

Curi Bio revenue

Curi Bio has not published its revenue. Growjo puts it at about $3.8M a year (December 2023).

$0
$1M
$2M
$3M
$0
–
$3.8M
20152016–222023
ReportedEstimateFounded 2015 at $0; every reading has its own bar
As ofRevenueSource
Dec 2023$3.8MESTGrowjo estimate

Who owns Curi Bio

Another company owns Curi Bio. The date and price of the deal are not on record.

Curi Bio CEO, founders & employees

Nicholas Geisse founded Curi Bio in 2015 and led it as CEO. Curi Bio had 52 employees (December 2023, Growjo estimate).

0
20
40
49
52
20222023
ReportedEstimateOne figure per year; a reported figure wins over an estimate
All 2 headcount readings, with sources
As ofEmployeesSource
Dec 202352ESTGrowjo estimate
Dec 202249ESTGrowjo estimate

Curi Bio FAQ

What was Curi Bio's revenue?

Growjo estimates Curi Bio's revenue at about $3.8M a year (December 2023). The company hasn't published its own figure.

How many employees does Curi Bio have?

Growjo estimates Curi Bio's headcount at about 52 (December 2023).

Who founded Curi Bio?

Nicholas Geisse founded Curi Bio in 2015.

How this page is sourced

3 estimates. Founder figures link to the second they were said; public figures name their source; estimates are marked EST and say whose they are. Not financial advice.

Updated Oct 5, 2026Data disclaimerReport a correctionClaim this profileRun Curi Bio? Join the podcast